CVS Health Lifts FY26 Outlook After Q1 Results Rise; Stock Gains

RTTNews | 128 days ago
CVS Health Lifts FY26 Outlook After Q1 Results Rise; Stock Gains

(RTTNews) - CVS Health Corp. on Wednesday reported higher profit and revenues in its first quarter and raised fiscal 2026 outlook.

According to the health solutions major, the updated outlook reflects increases in the Health Care Benefits and Pharmacy & Consumer Wellness segments. The company maintains a cautious view for the remainder of the year amid continued elevated cost trends and the potential for macro headwinds.

In pre-market activity, CVS shares were gaining around 4.7 percent to trade at $84.41, after closing Tuesday's regular trading 1.6 percent lower.

For fiscal 2026, the company now projects earnings per share to be $6.24 to $6.44, higher than previous estimate of $5.94 to $6.14.

Adjusted earnings per share are now expected between $7.30 and $7.50, compared to previous range of $7.00 to $7.20.

Total revenues for year are now expected to be at least $405.0 billion.

The Company in early December had issued guidance for total fiscal 2026 revenues of at least $400.0 billion

In fiscal 2025, earnings per share were $1.39 and adjusted earnings per share were $6.75 on revenues of $402.07 billion.

In the first quarter, CVS Health's net earnings totaled $2.943 billion or $2.30 per share, higher than $1.779 billion or $1.41 per share last year.

Adjusted earnings were $3.292 billion or $2.57 per share for the period, compared to $2.25 per share last year.

The company's revenue for the period rose 6.2% to $100.426 billion from $94.588 billion last year, driven by revenue growth across all operating segments.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

read more
CVS Health Lifts FY26 Outlook After Growth In Q2; Stock Gains

CVS Health Lifts FY26 Outlook After Growth In Q2; Stock Gains

Shares of CVS Health Corp. were gaining around 5 percent in the pre-market activity on the NYSE on Wednesday, after the firm lifted fiscal 2026 profit and revenue outlook, after reporting significant growth in its second quarter. According to the health solutions major, the outlook revision reflects increases in the Health Care Benefits and Pharmacy & Consumer Wellness segments.
RTTNews | 37 days ago
CVS Health Q4 Beats Street, Confirms FY26 Earnings View; Stock Down

CVS Health Q4 Beats Street, Confirms FY26 Earnings View; Stock Down

CVS Health Corp., while reporting higher profit and revenues in its fourth quarter above market estimates, on Tuesday confirmed its earnings outlook for fiscal 2026. Further, the company trimmed guidance foer cash flow from operations to at least $9.0 billion from at least $10.0 billion expected earlier. In pre-market activity, the shares were losing around 3.9 percent.
RTTNews | 213 days ago
CVS Health Reportedly Mulls Breakup, To Cut 2,900 Jobs

CVS Health Reportedly Mulls Breakup, To Cut 2,900 Jobs

CVS Health Corp. is conducting a strategic review of options including a possible breakup amid issues from its drugstore chain and Aetna health insurance arm, reports said citing person familiar with the matter. The company also plans to reduce its workforce by less than 1 percent, which would affect around 2,900 employees, as part of its cost-cutting efforts.
RTTNews | 710 days ago
CVS Offers Updated 2024-2025 COVID-19 And Flu Vaccines

CVS Offers Updated 2024-2025 COVID-19 And Flu Vaccines

CVS Health Corp. announced Wednesday the availability of updated 2024-2025 COVID-19 vaccines and flu vaccines at CVS Pharmacy and MinuteClinic locations across the United States. The U.S. Food and Drug Administration recently approved and granted emergency use authorization or EUA for updated Covid vaccines (2024-2025 formula) from Pfizer Inc. and ModernaTX Inc. for use against currently...
RTTNews | 744 days ago
CVS Health Slashes FY24 Outlook; Stock Down 11% - Update

CVS Health Slashes FY24 Outlook; Stock Down 11% - Update

While reporting financial results for the first quarter on Wednesday, CVS Health (CVS) slashed its earnings and adjusted earnings guidance for the full-year 2024, reflecting the potential for continued elevated medical cost trends in the remainder of 2024.
RTTNews | 863 days ago
P&G Recalls 8.2 Mln Defective Laundry Detergent Packets

P&G Recalls 8.2 Mln Defective Laundry Detergent Packets

Consumer goods giant Procter & Gamble Co. has called back around 8.2 million defective bags of Tide, Gain, Ace and Ariel laundry detergent packets distributed in the United States citing risk of serious injury, the U.S. Consumer Product Safety Commission announced. In addition, about 56,741 were sold in Canada. According to the agency, the outer packaging meant to prevent access to the contents...
RTTNews | 886 days ago
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews | 921 days ago
CVS Health Lowers FY24 Outlook - Update

CVS Health Lowers FY24 Outlook - Update

While reporting financial results for the fourth quarter on Wednesday, CVS Health (CVS) lowered its earnings and adjusted earnings guidance for the full-year 2024.
RTTNews | 947 days ago